Search by Drug Name or NDC
NDC 70518-1938-01 PRAVASTATIN SODIUM 20 mg/1 Details
PRAVASTATIN SODIUM 20 mg/1
PRAVASTATIN SODIUM is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by REMEDYREPACK INC.. The primary component is PRAVASTATIN SODIUM.
MedlinePlus Drug Summary
Pravastatin is used together with diet, weight-loss, and exercise to reduce the risk of heart attack and stroke and to decrease the chance that heart surgery will be needed in people who have heart disease or who are at risk of developing heart disease. Pravastatin is also used to reduce the amount of fatty substances such as low-density lipoprotein (LDL) cholesterol ('bad cholesterol') and triglycerides in the blood and to increase the amount of high-density lipoprotein (HDL) cholesterol ('good cholesterol') in the blood. Pravastatin is in a class of medications called HMG-CoA reductase inhibitors (statins). It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Accumulation of cholesterol and fats along the walls of your arteries (a process known as atherosclerosis) decreases blood flow and, therefore, the oxygen supply to your heart, brain, and other parts of your body. Lowering your blood level of cholesterol and fats with pravastatin has been shown to prevent heart disease, angina (chest pain), strokes, and heart attacks.
Related Packages: 70518-1938-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Pravastatin
Product Information
| NDC | 70518-1938 |
|---|---|
| Product ID | 70518-1938_f6510364-d41a-7ac3-e053-2995a90a62cb |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | PRAVASTATIN SODIUM |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | PRAVASTATIN SODIUM |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | PRAVASTATIN SODIUM |
| Labeler Name | REMEDYREPACK INC. |
| Pharmaceutical Class | HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA076341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70518-1938-01 (70518193801)
| NDC Package Code | 70518-1938-1 |
|---|---|
| Billing NDC | 70518193801 |
| Package | 90 TABLET in 1 BOTTLE, PLASTIC (70518-1938-1) |
| Marketing Start Date | 2019-04-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |